Dedifferentiated parosteal osteosarcoma of the femur with aneuploidy and lung metastases. 1989

M W van Oven, and W M Molenaar, and N J Freling, and H Schraffordt Koops, and N Muis, and A Dam-Meiring, and J W Oosterhuis
Department of Pathology, University Hospital of Groningen, The Netherlands.

In this report, the pathologic findings and the results of cellular DNA measurements of a tumor that on first presentation seemed to be a classical parosteal osteosarcoma are described. After resection 8 months later, part of the tumor appeared to display highly malignant features. DNA flow cytometry of this part of the tumor showed an aneuploid cell population. The aggressive nature of the tumor was confirmed by the development of lung metastases approximately 1 year after resection of the primary tumor.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005260 Female Females
D005266 Femoral Neoplasms New abnormal growth of tissue in the FEMUR. Femoral Neoplasm,Neoplasm, Femoral,Neoplasms, Femoral
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000782 Aneuploidy The chromosomal constitution of cells which deviate from the normal by the addition or subtraction of CHROMOSOMES, chromosome pairs, or chromosome fragments. In a normally diploid cell (DIPLOIDY) the loss of a chromosome pair is termed nullisomy (symbol: 2N-2), the loss of a single chromosome is MONOSOMY (symbol: 2N-1), the addition of a chromosome pair is tetrasomy (symbol: 2N+2), the addition of a single chromosome is TRISOMY (symbol: 2N+1). Aneuploid,Aneuploid Cell,Aneuploid Cells,Aneuploidies,Aneuploids,Cell, Aneuploid,Cells, Aneuploid
D012516 Osteosarcoma A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) Sarcoma, Osteogenic,Osteogenic Sarcoma,Osteosarcoma Tumor,Osteogenic Sarcomas,Osteosarcoma Tumors,Osteosarcomas,Sarcomas, Osteogenic,Tumor, Osteosarcoma,Tumors, Osteosarcoma

Related Publications

M W van Oven, and W M Molenaar, and N J Freling, and H Schraffordt Koops, and N Muis, and A Dam-Meiring, and J W Oosterhuis
October 2006, Skeletal radiology,
M W van Oven, and W M Molenaar, and N J Freling, and H Schraffordt Koops, and N Muis, and A Dam-Meiring, and J W Oosterhuis
January 1984, The Journal of bone and joint surgery. American volume,
M W van Oven, and W M Molenaar, and N J Freling, and H Schraffordt Koops, and N Muis, and A Dam-Meiring, and J W Oosterhuis
September 1999, Skeletal radiology,
M W van Oven, and W M Molenaar, and N J Freling, and H Schraffordt Koops, and N Muis, and A Dam-Meiring, and J W Oosterhuis
April 1997, Skeletal radiology,
M W van Oven, and W M Molenaar, and N J Freling, and H Schraffordt Koops, and N Muis, and A Dam-Meiring, and J W Oosterhuis
January 2018, Proceedings (Baylor University. Medical Center),
M W van Oven, and W M Molenaar, and N J Freling, and H Schraffordt Koops, and N Muis, and A Dam-Meiring, and J W Oosterhuis
March 1999, Archives of pathology & laboratory medicine,
M W van Oven, and W M Molenaar, and N J Freling, and H Schraffordt Koops, and N Muis, and A Dam-Meiring, and J W Oosterhuis
January 1988, Skeletal radiology,
M W van Oven, and W M Molenaar, and N J Freling, and H Schraffordt Koops, and N Muis, and A Dam-Meiring, and J W Oosterhuis
April 2008, Skeletal radiology,
M W van Oven, and W M Molenaar, and N J Freling, and H Schraffordt Koops, and N Muis, and A Dam-Meiring, and J W Oosterhuis
June 2005, Cancer,
M W van Oven, and W M Molenaar, and N J Freling, and H Schraffordt Koops, and N Muis, and A Dam-Meiring, and J W Oosterhuis
November 1980, Pathology, research and practice,
Copied contents to your clipboard!